Isolated limb perfusion with high-dose tumor necrosis factor-alpha in combination with interferon-gamma and melphalan for nonresectable extremity soft tissue sarcomas: a multicenter trial

J Clin Oncol. 1997 May;15(5):2174-5. doi: 10.1200/JCO.1997.15.5.2174.
No abstract available

Publication types

  • Comment
  • Letter

MeSH terms

  • Amputation, Surgical / statistics & numerical data
  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
  • Extremities*
  • Humans
  • Interferon-gamma / administration & dosage
  • Melphalan / administration & dosage
  • Multicenter Studies as Topic
  • Sarcoma / drug therapy*
  • Sarcoma / secondary*
  • Sarcoma / surgery
  • Survival Analysis
  • Tumor Necrosis Factor-alpha / administration & dosage

Substances

  • Tumor Necrosis Factor-alpha
  • Interferon-gamma
  • Melphalan